Interaction of glycyrrhetinic acid, furosemide and hydrochlorothiazide with bovine serum albumin and their displacement interactions: Capillary electrophoresis and fluorescence quenching study

Biomedical Chromatography

Volumn 22, Issue 3, 2008, Pages 223-231

  Zhou, Neng ^a,b   Liang, Yi Zeng ^a   Wang, Bing ^a   Wang, Ping ^a   Chen, Xian ^a   Zeng, Mao Mao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Yulin Teachers College   (China)

Author keywords

Bovine serum albumin; Capillary electrophoresis frontal analysis; Displacement interaction; Fluorescence quenching; Furosemide; Glycyrrhetinic acid; Hydrochlorothiazide

Indexed keywords

BINDING SITES; BODY FLUIDS; CAPILLARY ELECTROPHORESIS; MAMMALS; MEDICINE; SURFACE PLASMON RESONANCE;

BINDING-SITES; BOVINE SERUM ALBUMINS; CAPILLARY ELECTROPHORESIS FRONTAL ANALYSIS; DISPLACEMENT INTERACTION; DISPLACERS; FLUORESCENCE QUENCHING; FUROSEMIDES; GLYCYRRHETINIC ACIDS; HYDROCHLOROTHIAZIDE; QUENCHING STUDIES;

FLUORESCENCE QUENCHING;

BOVINE SERUM ALBUMIN; FUROSEMIDE; GLYCYRRHETINIC ACID; HYDROCHLOROTHIAZIDE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CAPILLARY ELECTROPHORESIS; CHINESE MEDICINE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DISPOSITION; DRUG PROTEIN BINDING; DRUG STRUCTURE; FLUORESCENCE SPECTROSCOPY; GLYCYRRHIZA; SCATCHARD PLOT; ULTRACENTRIFUGATION;

BOVINAE; GLYCYRRHIZA;

EID: 41549128499     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.923     Document Type: Article

References (40)

1. Abe H, Ohya N, Yamamoto KF, Shibuya T, Arichi S and Odashima S. Effects of glycyrrhizin and glycyrrhetinic acid on growth and melanogenesis in cultured B16 melanoma cells. European Journal of Cancer and Clinical Oncology 1987; 10: 1549-1553.
2. Ascoli G, Bertucci C and Salvadori P. Stereospecific and competitive binding of drugs to human serum albumin: a difference circular dichroism approach. Journal of Pharmaceutical Sciences 1995; 84: 737-741.
3. Borga O and Borga B. Serum protein binding of nonsteroidal antiinflammatory drugs: a comparative study. Journal of Pharmaceutical and Biomedical Analysis 1997; 25: 63-77.
4. Brustein EA, Vedenkina NS and Irkova MN. Fluorescence and the location of tryptophan residues in protein molecules. Photochemistry and Photobiology 1973; 18: 263-279.
5. Busch MBA, Carels LB, Boelens HFM, Kraak JC and Poppe H. Comparison of five methods for the study of drug-protein binding in affinity capillary electrophoresis. Journal of Chromatography A 1997; 777: 311-328.
6. Carter DC, He XM, Munson SH, Twigg PD, Gernert KM, Broom MB and Miller TY. Three-dimensional structure of human serum albumin. Science 1989; 244: 1195-1198.
7. Cszerhárti T and Forgács E. Charge transfer chromatographic study of the binding of commercial pesticides to various albumins. Journal of Chromatography A 1995; 699: 285-290.
8. Ding YS, Zhu XF and Lin BC. Capillary electrophoresis study of human serum albumin binding to basic drugs. Chromatographia 1999; 49: 343-346.
9. Edwards CRW and Teelucksingh S. Treatment of chronic hepatitis B. Part 2: effect of glycyrrhizic acid on the course of illness. The Lancet 1990; 8710: 322-323.
10. Fukai T, Marumo A, Kaitou K, Kanda T, Terada S and Nomura T. Anti-helicobacter pylori flavonoids from licorice extract. Life Sciences 2002; 71: 1449-1463.
11. Gao H, Lei LD, Liu JQ, Kong Q, Chen XG and Hu ZD. The study on the interaction between human serum albumin and a new reagent with antitumour activity by spectrophotometric methods. Journal of Photochemistry and Photobiology A - Chemistry 2004; 167: 213-221.
12. Gomez-Sanchez EP, Cox D, Foecking M, Ganjam V and Gomez-Sanchez CE. 11β-Hydroxysteroid dehydrogenases of the choriocarcinoma cell line JEG-3 and their inhibition by glycyrrhetinic acid and other natural substances. Steroids 1996; 61: 110-115.
13. Guzmán A, Agüí L, Pedrero M, Yáñez-Sedeño P and Pingarrón JM. Flow injection and HPLC determination of furosemide using pulsed amperometric detection at microelectrodes. Journal of Pharmaceutical and Biomedical Analysis 2003; 33: 923-933.
14. Horigome H, Hirano T and Oak K. Therapeutic effect of glycyrrhetinic acid in MRL lpr/lpr mice: Implications of alteration of corticosteroid metabolism. Life Sciences 2001; 69: 2429-2438.
15. Hussain RM. The sweet cake that reaches parts other cakes can't! Postgraduate Medical Journal 2003; 79: 115-116.
16. Imanishi N, Kawai H, Hayashi Y, Yatsunami K and Ichikawa A. Effects of glycyrrhizin and glycyrrhetinic acid on dexamethasone-induced changes in histamine synthesis of mouse mastocytoma P-815 cells and in histamine release from rat peritoneal mast cells. Biochemical Pharmacology 1989; 15: 2521-2526.
17. Jeong HG, You HJ, Park SJ, Moon AR, Chng YC, Kang SK and Chun HK. Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression. Pharmacological Research 2002; 3: 221-227.
18. Kamat BP and Seetharamappa J. In vitro study on the interaction of mechanism of tricyclic compounds with bovine serum albumin. Journal of Pharmaceutical and Biomedical Analysis 2004; 35: 655-664.
19. Kang J, Liu Y, Xie MX, Li S, Jiang M and Wang YD. Interactions of human serum albumin with chlorogenic acid and ferulic acid. Biochimica et Biophysica Acta 2004; 1674: 205-214.
20. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacological Reviews 1981; 33: 17-53.
21. Kurz H. Drug Protein Binding. Praeger: New York, 1986; 70-92.
22. Kwong TC. Free drug measurements: methodology and clinical significance. Clinical Chimica Acta 1985; 151: 193-216.
23. Lakowicz JR. Principles of Fluorescence Spectroscopy, 2nd edn. Plenum Press: New York, 1999.
24. Lin G, Nnane IP and Cheng TY. The effects of pretreatment with glycyrrhizin and glycyrrhetinic acid on the retrorsine-induced hepatotoxicity in rats. Toxicon 1999; 37: 1259-1270.
25. Liu F, Xu Y, Gao S, Zang J and Guo Q. Determination of hydrochlorothiazide in human plasma by liquid chromatography/tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2007; 44: 1187-1191.
26. Marandici A and Monder C. Inhibition by glycyrrhetinic acid of rat tissue 11 beta-hydroxysteroid dehydrogenase in vivo. Steroids 1993; 58: 153-156.
27. Martínez-Gómez MA, Sagrado S, Villanueva-Camañs RM and Medina-Hernndez MJ. Characterization of basic drug-human serum protein interactions by capillary electrophoresis. Electrophoresis 2006; 2: 3410-3419.
28. Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D and Edwards CR. Licorice inhibits corticosteroid 11β-hydroxysteroid dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology 1989; 125: 1046-1053.
29. Øtergaard J and Heegaard NHH. Capillary electrophoresis frontal analysis: principles and applications for the study of drug-plasma protein binding. Electrophoresis 2003; 24: 2903-2913.
30. Ou SY and Kwok KC. Ferulic acid:pharmaceutical functions, preparation and applications in foods. Journal of the Science of Food and Agriculture 2004; 84: 1261-1269.
31. Parikh HH, McElwain K, Balasubramanian V, Leung W, Wong D, Morris ME and Ramanathan M. A rapid spectrofluorimetric technique for determining drug-serum protein binding suitable for high-throughput screening. Pharmaceutical Research 2000; 17(5): 632-637.
32. Reed MD, Myers CM and Blumer JL. Influence of midazolam on the protein binding of ketorolac. Current Therapeutic Research 2001; 8: 558-565.
33. Rieutord A, Bourget P, Torche G and Zazzo JF. In vitro study of the protein binding of fusidic acid: a contribution to the comprehension of its pharmacokinetic behaviour, International Journal of Pharmaceutics 1995; 119: 57-62.
34. Salvi M, Fiore C, Armanini D and Toninello A. Glycyrrhetinic acid-induced permeability transition in rat liver mitochondria. Biochemical Pharmacology 2003; 66: 2375-2379.
35. Seedher N. In vitro study of the mechanism of interaction of trifluoperazine dihydrochlorida with bovine serum albumin. Indian Journal of Pharmaceutical Sciences 2000; 62: 16-20.
36. Silva D, Cortez CM, Cunha-Bastos J and Louro SRW. Methyl parathion interaction with human and bovine serum albumin. Toxicology Letters 2004; 147: 53-61.
37. Yamasaki K, Maruyama T, Kragh-Hansen U and Otagiri M. Characterization of site I on human serum albumin: concept about the structure of a drug binding site. Biochimica et Biophysica Acta 1996; 1295: 147-157.
38. Zhang YT, Xu MT, Du M and Zhou FM. Comparative studies of the interaction between ferulic acid and bovine serum albumin by ACE and surface plasmon resonance. Electrophoresis 2007; 28: 1839-1845.
39. Zhou N, Liang YZ and Wang P. Characterization of the interaction between furosemide and bovine serum albumin. Journal of Molecular Structure 2007 (in press); doi:10.1016/j.molstruc.2007.02.035.
40. Zlotos G, Bucker A, Kinzig-Schippers M, Sorge F and Holzgrabe U. Plasma protein binding of gyrase inhibitors. Journal of Pharmaceutical Sciences 1998; 87: 215-219.